Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?

Publication date: Available online 11 January 2021Source: Gynecologic Oncology ReportsAuthor(s): Varun Khetan, Erin A. Blake, Marcia A. Ciccone, Koji Matsuo
Source: Gynecologic Oncology Reports - Category: OBGYN Source Type: research